Identification of novel membrane markers in circulating tumor cells of mesenchymal state in breast cancer
Cancer metastasis is a major cause of cancer-related deaths worldwide. The ability to detect and monitor circulating tumor cells (CTCs) offers a promising approach to early detection and management of metastasis. Although studies on epithelial markers for CTC detection are actively underway, the dis...
Main Authors: | Yongdeuk Hwang, Yurim Kim, Jiin Min, Jinmyung Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-07-01
|
Series: | Biochemistry and Biophysics Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580824000165 |
Similar Items
-
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer
by: Xiuwen Guan, et al.
Published: (2019-01-01) -
Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?
by: Ivana Fridrichova, et al.
Published: (2022-10-01) -
Prognostic value of epithelial–mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis
by: Qiang Zhao, et al.
Published: (2022-11-01) -
Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy
by: Takahiro Okabe, et al.
Published: (2020-11-01) -
Identification of Breast Cancer Metastasis Markers from Gene Expression Profiles Using Machine Learning Approaches
by: Jinmyung Jung, et al.
Published: (2023-09-01)